Back

Impact and role of proteomics in cardiovascular disease

28 August 2017 (14:22 - 14:45)
Organised by:
Congress Presentation Part of: Dissecting the secretome in the "omics" era Metabolism and metabolic syndromes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Manuel Mayr

National Heart and Lung Institute Imperial College, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Metabolomic profiling in cardiac hypertrophy and failure.
Professor C. Perrino (Naples, IT)
Slides Video
Presentation thumbnail
Lipidomics to discover new biomarkers for cardiovascular risk
Doctor R. Laaksonen (Tampere, FI)
Slides Video
Presentation thumbnail
Extra cellular vesicles as biomarkers and novel therapeutic targets.
Professor J. Sluijter (Utrecht, NL)
Slides Video

Access the full session

Session thumbnail
Dissecting the secretome in the "omics" era

The Event

Event poster

ESC Congress 2017

28 August 2017 14:22 CET
You may be interested in
thumbnail
Congress Presentation
Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy
28 August 2022
thumbnail
Congress Session
What’s on the horizon in heart failure: precision medicine and tailored treatment
18 May 2025
thumbnail
Congress Presentation
Proteomic differences associated to cardiovascular disease among apparently healthy women with previous spontaneous preterm birth
30 August 2026
thumbnail
Congress Presentation
The urinary proteomic profile of arterial stiffness in the general population
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources